Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines.
Fibroblast growth factors (FGFs) mediate a vast range of CNS developmental processes including neural induction, proliferation, migration, and cell survival. Despite the critical role of FGF signaling for normal CNS development, few reports describe the mechanisms that regulate FGF receptor gene expression in the brain. We tested whether FGF8 could autoregulate two of its cognate receptors, Fgfr1 and Fgfr3, in three murine cell lines with different lineages: fibroblast-derived cells (3T3 cells), neuronal cells derived from hippocampus (HT-22 cells), and neuroendocrine cells derived from hypothalamic gonadotropin-releasing hormone (GnRH) neurons (GT1-7 cells). GnRH is produced by neurons in the hypothalamus and is absolutely required for reproductive competence in vertebrate animals. Several lines of evidence strongly suggest that Fgf8 is critical for normal development of the GnRH system, therefore, the GT1-7 cells provided us with an additional endpoint, Gnrh gene expression and promoter activity, to assess potential downstream consequences of FGF8-induced modulation of FGF receptor levels. Results from this study suggest that the autoregulation of its cognate receptor represents a common downstream effect of FGF8. Further, we show that Fgfr1 and Fgfr3 are differentially regulated within the same cell type, implicating these two receptors in different biological roles. Moreover, Fgfr1 and Fgfr3 are differentially regulated among different cell types, suggesting such autoregulation occurs in a cell type-specific fashion. Lastly, we demonstrate that FGF8b decreases Gnrh promoter activity and gene expression, possibly reflecting a downstream consequence of altered FGF receptor populations. Together, our data bring forth the possibility that, in addition to the FGF synexpression group, autoregulation of FGFR expression by FGF8 represents a mechanism by which FGF8 could fine-tune its regulatory actions.
Mott
Natasha N
NN
Department of Cell and Molecular Physiology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, United States of America.
Chung
Wilson C J
WC
Tsai
Pei-San
PS
Pak
Toni R
TR
D000818:Animals; D001923:Brain Chemistry; D002460:Cell Line; D019070:Cell Lineage; D051524:Fibroblast Growth Factor 8 / Q000502:physiology*; D005347:Fibroblasts / Q000166:cytology; D005786:Gene Expression Regulation; D007987:Gonadotropin-Releasing Hormone; D006624:Hippocampus / Q000166:cytology; D007031:Hypothalamus / Q000166:cytology; D051379:Mice; D009474:Neurons / Q000378:metabolism*; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics*; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics*
D051524:Fibroblast Growth Factor 8; D007987:Gonadotropin-Releasing Hormone; C496349:Fgfr1 protein, mouse; C496366:Fgfr3 protein, mouse; D051496:Receptor, Fibroblast Growth Factor, Type 1; D051498:Receptor, Fibroblast Growth Factor, Type 3
Cell Tissue Res. 2003 Aug;313(2):139-57
12845521
Dev Biol. 2010 Feb 15;338(2):183-92
19968985
J Biol Chem. 1996 Mar 8;271(10):5663-70
8621430
Endocrinology. 2006 Apr;147(4):1924-31
16439454
Development. 2007 Jun;134(12):2251-60
17507393
J Biol Chem. 1985 Nov 5;260(25):13860-8
2997183
Mol Endocrinol. 2005 Jan;19(1):225-36
15459253
ACS Chem Biol. 2008 Sep 19;3(9):530-41
18652471
Trends Biochem Sci. 2003 Jul;28(7):369-76
12878004
Nature. 1999 Sep 30;401(6752):480-5
10519551
Dev Genes Evol. 2004 Jun;214(6):285-95
15221377
EMBO J. 1998 Oct 15;17(20):5896-904
9774334
Endocrinology. 2004 Aug;145(8):3830-9
15117872
Endocrinology. 1994 Mar;134(3):1467-74
8119188
J Biol Chem. 2006 Jun 9;281(23):15694-700
16597617
Dev Biol. 2005 Mar 1;279(1):73-85
15708559
Neuron. 1990 Dec;5(6):875-80
1980069
Endocrinology. 2008 Oct;149(10):4997-5003
18566132
Oncogene. 2004 Apr 29;23(20):3501-8
15116089
J Neurochem. 2000 Oct;75(4):1520-7
10987832
Leukemia. 2004 May;18(5):962-6
15029211
Genes Dev. 1999 Jun 1;13(11):1486-99
10364164
Endocrinology. 2009 May;150(5):2308-16
19147677
Genes Dev. 2001 Aug 1;15(15):1885-99
11485984
Clin Cancer Res. 2009 Jan 15;15(2):441-51
19147748
J Neurochem. 2007 Mar;100(6):1565-78
17181553
Oncogene. 2005 Jan 27;24(5):945-8
15558020
J Cell Physiol. 2008 Jul;216(1):261-8
18286540
Nature. 2002 May 2;417(6884):35-6
11986655
Mol Endocrinol. 2006 Sep;20(9):1972-81
16423879
Cancer Res. 2009 Jun 1;69(11):4613-20
19458078
Endocr Relat Cancer. 2004 Dec;11(4):709-24
15613447
J Cell Biol. 1989 Nov;109(5):2519-27
2553749
Diabetes. 2007 Jan;56(1):96-106
17192470